By rray, 15 March, 2023 Consult w multidisciplinary team for immunomodulatory tx mgmt for children w MIS C which may include cardiology hematology infectious disease intensive care rheumatology
By rray, 15 March, 2023 Consider adding baricitinib2 or tocilizumab if no rapid improvement in oxygenation w in 24h of tx
By rray, 15 March, 2023 Consider adding baricitinib2 or tocilizumab if no rapid improvement in oxygenation w in 24h of tx
By rray, 15 March, 2023 Note Activity of anti SARS CoV 2 specific monoclonal antibodies against currently circulating variants is significantly reduced tx w these agents is NOT recommended